Disease Specific Guides to Medication Review
Managing Medicines in Schizophrenia
A new guide to medicines management in schizophrenia has been developed by Bristol Myers Squibb and Otsuka Pharmaceuticals. The guide is particularly intended to help NHS Organisations to meet NICE guidelines on atypical antipsychotic medication by ensuring that patients with schizophrenia have their medicines appropriately reviewed and are referred where indicated, for more in-depth review. The guide consists of a number of modules:
The guide was reviewed by an expert advisory group including a Clinical Pharmacist in a specialist Psychiatric centre, a PCT Pharmaceutical Advisor and a Community Psychiatric Nurse, and also had input from Medicines Partnership.
A copy of the guide can be obtained, free of charge, by contacting:
Epilepsy Action's Epilepsy Resource Pack
Epilepsy Action, supported by an educational grant from GlaxoSmithKline, has produced a toolkit to help health professionals in primary care to improve local medication review services for patients with epilepsy.
The toolkit includes a step by step guide to:
Standard template forms and letters are included, including template seizure diaries which can be kept by patients and a checklist of information for patients and carers.
An information section in the toolkit provides a review of best practice in primary care epilepsy management and sources of additional information and guidance.
A CD ROM accompanies the toolkit with template forms and letters in electronic form.
The toolkit and information section can be downloaded from the Epilepsy Action website at: www.epilepsy.org.uk/gpresource/
Or ordered from:
New Anstey House
Gate Way Drive
Leeds LS19 7XY
Tel: 0113 210 8800